Influenza A (H1N1): outbreak management in a dialysis unit and clinical outcomes of infection in chronic hemodialysis patients.


Journal

Jornal brasileiro de nefrologia
ISSN: 2175-8239
Titre abrégé: J Bras Nefrol
Pays: Brazil
ID NLM: 9426946

Informations de publication

Date de publication:
23 Mar 2020
Historique:
received: 17 09 2019
accepted: 14 10 2019
pubmed: 1 4 2020
medline: 4 5 2021
entrez: 1 4 2020
Statut: ppublish

Résumé

Chronic hemodialysis (HD) patients are considered to be at high risk for infection. Here, we describe the clinical outcomes of chronic HD patients with influenza A (H1N1) infection and the strategies adopted to control an outbreak of influenza A in a dialysis unit. Among a total of 62 chronic HD patients, H1N1 infection was identified in 12 (19.4%). Of the 32 staff members, four (12.5%) were found to be infected with the H1N1 virus. Outcomes included symptoms at presentation, comorbidities, occurrence of hypoxemia, hospital admission, and clinical evaluation. Infection was confirmed by real-time reverse transcriptase polymerase chain reaction. The 12 patients who had H1N1 infection did not differ significantly from the other 50 non-infected patients with respect to age, sex, dialysis vintage, dialysis modality, or proportion of comorbidities. Obesity was higher in the H1N1-infected group (41.5 vs. 4%, p<0.002). The most common symptoms were fever (92%), cough (92%), and rhinorrhea (83%). Early empirical antiviral treatment with oseltamivir was started in symptomatic patients and infection control measures, including the intensification of contact-reduction measures by the staff members, antiviral chemoprophylaxis to asymptomatic patients undergoing HD in the same shift of infected patients, and dismiss of staff members suspected of being infected, were implemented to control the spread of infection in the dialysis unit. The clinical course of infection with H1N1 in our patients was favorable. None of the patients developed severe disease and the strategies adopted to control the outbreak were successful.

Identifiants

pubmed: 32227069
pii: S0101-28002020005007202
doi: 10.1590/2175-8239-jbn-2019-0180
pmc: PMC7427650
pii:
doi:

Substances chimiques

Antiviral Agents 0
Influenza Vaccines 0
Oseltamivir 20O93L6F9H

Types de publication

Journal Article

Langues

eng por

Sous-ensembles de citation

IM

Pagination

182-190

Références

Kidney Int. 2003 Feb;63(2):738-43
pubmed: 12631142
N Engl J Med. 2009 Dec 17;361(25):2493
pubmed: 19923563
J Am Soc Nephrol. 2004 Jul;15(7):1883-8
pubmed: 15213277
J Antimicrob Chemother. 2003 Jan;51(1):123-9
pubmed: 12493796
Nephrol Dial Transplant. 2009 Dec;24(12):3566-72
pubmed: 19846392
Curr Opin Nephrol Hypertens. 2016 Nov;25(6):465-472
pubmed: 27490909
Ann Lab Med. 2016 May;36(3):255-8
pubmed: 26915615
Perit Dial Int. 2011 May-Jun;31(3):347-50
pubmed: 21555416
Clin Infect Dis. 2019 Mar 5;68(6):e1-e47
pubmed: 30566567
Kidney Int Suppl. 1993 Jun;41:S135-42
pubmed: 8320907
N Engl J Med. 2010 May 6;362(18):1708-19
pubmed: 20445182
Influenza Other Respir Viruses. 2014 Jan;8(1):74-82
pubmed: 24373292
Nephron. 1993;63(2):125-31
pubmed: 8450902
Lancet Infect Dis. 2009 Aug;9(8):493-504
pubmed: 19628174
Blood Purif. 2010;30(3):172-7
pubmed: 20924171
Antimicrob Agents Chemother. 2015 Nov;59(11):6774-81
pubmed: 26282419
Clin J Am Soc Nephrol. 2011 Sep;6(9):2208-14
pubmed: 21852661
Nephrol Dial Transplant. 2006 Sep;21(9):2556-62
pubmed: 16799169
Vaccine. 2004 Jun 2;22(17-18):2199-201
pubmed: 15149777
Am J Kidney Dis. 2009 Jul;54(1):77-85
pubmed: 19339089

Auteurs

Carlucci Gualberto Ventura (CG)

Hospital Sírio-Libanês, Centro de Nefrologia e Diálise, São Paulo, SP, Brasil.

Felício Lopes Roque (FL)

Hospital Sírio-Libanês, Centro de Nefrologia e Diálise, São Paulo, SP, Brasil.

Itanilton Queiroz de Sousa (IQ)

Hospital Sírio-Libanês, Centro de Nefrologia e Diálise, São Paulo, SP, Brasil.

Renata Desordi Lobo (RD)

Hospital Sírio-Libanês, Controle de Doenças Infecciosas, São Paulo, SP, Brasil.

Claudio Luders (C)

Hospital Sírio-Libanês, Centro de Nefrologia e Diálise, São Paulo, SP, Brasil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH